Longer-Term Outcomes of Combined Tolterodine and Vaginal Estradiol Cream for Overactive Bladder Symptoms After Single-Therapy Treatment

Ellington D1, Malek J1, Szychowski J2, Kimberly G3, Burgio K4, Richter H1

Research Type


Abstract Category

Overactive Bladder

Abstract 493
Pharmacotherapy for Overactive Bladder
Scientific Podium Short Oral Session 34
Friday 9th October 2015
09:45 - 09:52
Overactive Bladder Clinical Trial Quality of Life (QoL) Prospective Study
1. University of Alabama at Birmingham, Division of Urogynecology and Pelvic Reconstructive Surgery, 2. University of Alabama at Birmingham, Division of Biostatistics, 3. Park Nicollet Health, Urogynecology and Reconstructive Pelvic Surgery, 4. University of Alabama at Birmingham, Department of Medicine, Birmingham/Atlanta Geriatric Research, Education, and Clinical Center, Department of Veterans Affairs

David Ellington